Related Experiment Video
Updated: May 7, 2026

Working with Human Tissues for Translational Cancer Research
Published on: November 26, 2015
Patients' motives for consenting or refusing to participate in a clinical trial in organ transplantation
Myriam Guedj1, Sandrine Ballester, Nassim Kamar
1Department of Psychology, University Toulouse II le Mirail, Toulouse, Midi Pyrénées, France.
Background:
The goal of this health-psychology study was to investigate the range of motives that make someone consent or refuse participation in a clinical transplant trial.
Methods:
The study involved (i) preparatory interviews with five transplant patients who took part in clinical trials and five persons from the general public; (ii) we created a questionnaire with scaled responses; (iii) we selected 468 patients, divided into two groups: patients waiting for a transplant and patients who already had a transplant; (iv) we obtained patient consents, sent out the questionnaire, and recorded responses; (v) data were analysed using descriptive statistics, exploratory factorial analyses, correlations and regressions.
Results:
Two hundred and ten patients answered the questionnaire. Motives were classified into the following: (i) Motives to consent participating in a clinical trial (pride in participating, hope for better quality of life, sufficient and clear information, discussion with others participating in a trial, altruism); or (ii) Motives to refuse participating (no information on medical teams, lack of explanation, fear of additional expenses, being considered a "guinea pig").
Conclusions:
This study contributes to our understanding of the motivations of patients who accepted or refused participation in a clinical transplantation trial.
Related Concept Videos
Kidney Transplant I: Introduction
Bioavailability Study Design: Healthy Subjects Versus Patients
Clinical Trials
There are four phases in a clinical trial. A phase one...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Kidney Transplant II: Surgical Procedure

